VERMES Microdispensing engages in the European Development Project – DIACHEMO – for optimizing tumor treatment

DIACHEMO_Announcement.jpg

VERMES Microdispensing engages in European Development Project to design a microfluidic analysis device.

The research project is dedicated to the development of a microfluidic analysis device for the rapid quantification of chemotherapeutic drugs.

VERMES Microdispensing’s goals are to advance the pace of smallest particle extraction in body fluid by fostering its decades of dispensing knowhow.

 

MUNICH, Germany, September 18, 2018 – VERMES Microdispensing, the world’s leading manufacturer of precision dispensing systems, has engaged in the European Development Project – DIACHEMO.

The DIACHEMO project, funded by the European Union’s Horizon 2020 Research and Innovation Program is dedicated to the development of a microfluidic analysis device for the rapid quantification of chemotherapeutic drugs in the circulation of a tumor or leukemia patient.

By leveraging decades of scientific understanding from studies and care of chemotherapeutical cancer treatment with the micro dispensing knowhow of VERMES Microdispensing, the team wants to help the medical practitioners to fine-tune their medical treatment.

“The task force’s goal is to enable the establishment of an optimized cancer treatment database, where the new device is to quantify chemotherapeutic drugs in small samples of body fluids by highly selective minimal particle extraction and liquid crystal detection,” explains Juergen Staedtler, CEO and Managing Director of VERMES Microdispensing.

These collective efforts are not intended to replace existing cancer programs, initiatives, and policies already underway, but rather are focused on areas in which a coordinated effort can accelerate the pace of progress in oncology treatment.

The methods currently in use, in order to determine the amount of active chemotherapeutic agents in the human body are time consuming, costly and require a complex laboratory environment.

At present, the dosages of anti-tumor drugs are determined based on body surface area. However, due to endogenous processes, such as metabolism, the concentration of active therapeutics in the body is subject to fluctuations.

Timely determination of existing drug concentrations is difficult. This may lead to misjudgments in the therapy by the attending physician and possibly to over or under-dose. Therefore the therapy might be less efficient.

Years of experience and competence in the field of microdispensing make VERMES Microdispensing a highly qualified partner for process implementation and system integration. VERMES Microdispensing supports the DIACHEMO project by developing, designing and building a point-of-care device for semi-automatic in vitro diagnostics.

The sensing device will measure, in real-time and with high precision, the concentration of the given drugs by using very small body fluids samples. The objective is to help the oncologist in decision making on dosage of such drugs in patients by providing a rapid, quantitative, and portable detection system.

Today researchers are working with an unprecedented amount of data. The project team therefore aims to develop and provide a reliable and inexpensive way of adapting dosing of anticancer drugs according to patients individual pharmacokinetics.

 

About us

VERMES Microdispensing world renowned high precision MDS Micro Dispensing Systems are the solution of choice for modern manufacturing processes throughout the globe in automotive, pharmacology, smart phones, TV sets, lamps, wafers, automated manufacture of LEDs, MEMS components, RFID tags, LC displays and many other electronic devices.

Headquartered in Germany, VERMES Microdispensing is an ISO 9001 certified company that revolutionized microdispensing technology with the introduction of its contact free piezo based MDS 3000 series in 2001. Today, the company is a world leader in the design and manufacture of innovative microdispensing concepts and systems for adhesives, silicones, greases, solvents and other fluids.

A world-class knowledge base, unparalleled design expertise, and extensive manufacturing capacity, enables the company to respond quickly and effectively to changing market conditions and the needs of its customers.

Our systems enable our customers to achieve contact free dispensing of highly viscous media droplets in the micro and nano-liter range at theoretical frequencies of more than 3000 Hz; a rate that is unique in our industry.

VERMES Microdispensing employees are dedicated to providing the best technologies and services to its customers around the world with the ultimate aim of contributing to increased throughput, improved quality and lower production costs.

For more information about VERMES Microdispensing, visit www.vermes.com.

VERMES Microdispensing is a trademark of VERMES Microdispensing GmbH in Germany and other countries.

Other names and brands may be claimed as the property of others.

 

 

Contact
Birgitt Harrow
VERMES Microdispensing GmbH

Palnkamer Str. 18

83624 Otterfing, Germany
Phone:    +49 (0) 80 24-6-44-335

Fax:         +49 (0) 80 24-6-44-19

pr@vermes.com

www.vermes.com

0

Start typing and press Enter to search